Medical News

RSS

Baxter commences BAX 111 Phase III trial in von Willebrand disease

Baxter International Inc. today announced initiation of a Phase III clinical trial to evaluate the safety and effectiveness of BAX 111, Baxter's investigational recombinant von Willebrand factor (rVWF), for the treatment and prevention of bleeding episodes in patients with von Willebrand disease.

From Baxter International Inc. 14 Oct 2011

WuXi PharmaTech announces acquisition of Abgent

WuXi PharmaTech Inc., a leading pharmaceutical, biotechnology and medical device research and development services company with operations in China and the United States, today announced the acquisition of Abgent, Inc., a provider of biological research reagent products and services based in Suzhou, China, and San Diego, California.

14 Oct 2011

InnaVirVax announces Phase I/IIa clinical trial authorization for its VAC-3S HIV vaccine

InnaVirVax, a biopharmaceutical company dedicated to the development of therapeutic and diagnostic solutions in pathologies associated with immune dysregulation, declared today that it has obtained authorization from the French drug agency (AFSSAPS) to start a Phase I/IIa clinical study of its therapeutic vaccine VAC-3S for the treatment of HIV infections. This authorization intervenes only two years and half after the launching of InnaVirVax’s activities.

14 Oct 2011

Viewpoints: 'Moneyball' and health care; Daschle on diabetes treatment; Elton John and Sen. Nelson on paying for AIDS drugs

Billy Beane's data-driven strategies made him the talk of baseball, the king of the current box office and a highly visible advocate for evidence-based medicine. But Beane's teams have faded since their "Moneyball" heyday - and evidence-based medicine might not be the home run that some reformers hope it will be.

14 Oct 2011

UMA to sponsor 'Learn for the Cure' breast cancer initiative

In honor of National Breast Cancer Awareness Month, Ultimate Medical Academy (UMA) will be sponsoring a "Learn for the Cure" initiative, which will take place October 17-23, 2011.

13 Oct 2011

Top-line results from POZEN's PA32540 Phase 3 trial on aspirin-associated gastric ulcers

POZEN Inc., a pharmaceutical company committed to transforming medicine that transforms lives, announced today top-line results from study 303, a Phase 3 trial designed to track the long-term safety of PA32540 in patients who are at risk for developing aspirin-associated gastric ulcers.

13 Oct 2011

Univita earns Health Utilization Management Accreditation from URAC

Univita announced today that it has been awarded Health Utilization Management Accreditation from URAC, a Washington, DC-based health care accrediting organization that establishes quality standards for the health care industry.

13 Oct 2011

Echo Therapeutics to begin Symphony tCGM System clinical study in Type 1 and Type 2 diabetes

Echo Therapeutics, Inc., a company developing the Symphony tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and the Prelude® SkinPrep System for transdermal drug delivery, today announced that it is initiating a clinical study of its Symphony tCGM System in patients with Type 1 and Type 2 diabetes.

13 Oct 2011

First Edition: October 13, 2011

In today's headlines, a report about how Mitt Romney's health law waiver plan would work -- states could skirt some of the measure's biggest requirements, but it's still not a complete repeal.

13 Oct 2011

Bruker acquires Center for Tribology

Bruker Corporation today announced the closing of its acquisition of Center for Tribology, Inc. (CETR) for $13 million in cash as an initial purchase price, with potential additional earn-out payments of up to $4 million in cash, depending on growth and profitability of the CETR-business within Bruker in 2012 and 2013.

From Bruker Nano Surfaces and Metrology 13 Oct 2011

Hydromorphone can be as effective as diacetylmorphine in treating heroin addiction

A clinical trial to test better treatment options for chronic heroin addiction is expected to begin in Vancouver at the end of this year. Led by researchers from Providence Health Care and the University of British Columbia, it's the only clinical trial of its kind in North America.

13 Oct 2011

Researchers use gold nanorods to distinguish brain tumor from healthy tissue

"It's not brain surgery" is a phrase often uttered to dismiss a job's difficulty, but when the task actually is removing a brain tumor, even the slightest mistake could have serious health consequences. To help surgeons in such high-pressure situations, researchers from Prof. Adam Wax's team at Duke University's Fitzpatrick Institute for Photonics and Biomedical Engineering Department have proposed a way to harness the unique optical properties of gold nanoparticles to clearly distinguish a brain tumor from the healthy, and vital, tissue that surrounds it.

13 Oct 2011

UofL researchers to develop treatments for chlorine-induced lung injuries

Gary Hoyle, PhD, professor, University of Louisville School of Public Health and Information Sciences, will build on his research to develop an effective medical treatment to counteract chlorine-induced lung injuries caused by chemical accidents or acts of terrorism.

13 Oct 2011

Laser-based analysis method can detect optical pressure differences in blood cells

U.S. Naval Research Laboratory researchers Dr. Sean J. Hart, Dr. Colin G. Hebert and Mr. Alex Terray have developed a laser-based analysis method that can detect optical pressure differences between populations or classes of blood cells that does not rely on prior knowledge, antibodies, or fluorescent labels for discrimination.

13 Oct 2011

Improved SNAP benefit levels more effective for children's health

Pediatric researchers from Boston Medical Center (BMC), in partnership with Children's HealthWatch investigators in Boston, Minneapolis, Little Rock, Philadelphia, and Baltimore, have found that higher benefit amounts in the Supplemental Nutrition Assistance Program protected the health and well-being of very young, low-income children during a period of great financial hardship for many families in America.

13 Oct 2011

Scientists reprogram skin cells of patients with mental disorders into brain cells

For many poorly understood mental disorders, such as schizophrenia or autism, scientists have wished they could uncover what goes wrong inside the brain before damage ensues.

13 Oct 2011

HHS: Pica eating disorder hospitalizations on the rise in the U.S.

An unusual eating disorder that many people have never even heard of is attracting attention because of a recent government study that indicated the disorder is on the rise in the United States.

13 Oct 2011

New insights into how adenovirus triggers an immune response

A Loyola University Chicago Stritch School of Medicine study could lead to improved gene therapies for conditions such as heart disease and cancer as well as more effective vaccines for tuberculosis, malaria and other diseases.

13 Oct 2011

UofL associate professor to create an emergency countermeasure staffing plan

Building on the success of Louisville's response to the 2009 H1N1 influenza pandemic, Ruth Carrico, PhD, plans to use a $250,000 one-year cooperative agreement from the Centers for Disease Control and Prevention (CDC) to create an emergency countermeasure staffing plan that utilizes nursing, pharmacy and public health students.

13 Oct 2011

Expert identifies employment resources for people with autism

Statistics show that the number of people diagnosed with autism has increased steadily over the past 30 years resulting in a surge in the number of adults with autism graduating from high school. However, preliminary employment studies indicate that this population may earn less and be employed at a lower rate compared to other people with disabilities.

13 Oct 2011